Abstract Details

Title Immunogenicity of PEGylated Interferon Beta-1a: Data from Preclinical and Phase 1 Clinical Studies

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 141

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Darren P. Baker, PhD (Sanofi Genzyme)	Dr. Baker has received personal compensation for serving as an employee of Sanofi. Dr. Baker has received stock or an ownership interest from Sanofi.
	No disclosure on file
Meena Subramanyam, PhD	No disclosure on file
	No disclosure on file
Gudarz Davar, MD (Allergan, Inc.)	No disclosure on file
Susan E. Goelz, PhD (myelin repair foundation)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����